Skip to main content
OpenTrials
Completed

NCT Number: NCT07218419

Comparison of Methods for Assessing Intraocular Lens Position

Prospective, multi-center, non-interventional, open label, clinical study.

Completed

Looking for future studies?

Notify Me

Key information

Age range

22 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Empire Eye & Laser Center, Bakersfield, California, United States

Loading trial locations.

About this study

The objective is to evaluate two methods for assessing IOL tilt and decentration in patients who have been unilaterally or bilaterally implanted with a refractive or diffractive nontoric TECNIS IOL before participating into this study. The agreement will be assessed between the decentration measurements derived from retro-illuminated slit lamp image analysis and those obtained from the subjective slit lamp grading method.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion:

All criteria apply to study eye.

The subject must:

  • Read, understand, and sign the informed consent and HIPAA authorization forms, and receive a fully executed copy of the signed forms.
  • Appear capable and willing to adhere to the clinical protocol procedures.
  • Be 22 years of age or older at the time of screening.
  • Have undergone unilateral or bilateral implantation with a desired TECNIS non-toric IOL design (e.g., refractive or diffractive).
  • Be at least three months postoperative in the study eye.

Exclusion:

All criteria apply to study eye.

The subject must NOT:

  • Any medical or ocular history, in the opinion of the investigator, that may impact study procedures such as ocular trauma, pseudoexfoliation syndrome, retinal pigment degeneration, macular pathology, glaucoma, retinal disease, corneal disease, or corneal opacities.
  • Have any condition that may affect the eye's ability to fixate (e.g., amblyopia).
  • Have a history of corneal or intraocular surgery other than cataract surgery.
  • Be using ocular or systemic medications known to interact with dilation drops.
  • Have a history of hypersensitivity, allergic reaction or other contraindication to dilation drops.
  • Have clinically significant pupil abnormalities (e.g., non-reactive, fixed, or abnormally shaped pupils).
  • Have an intraocular pressure of ≥ 21mm Hg before mydriasis.
  • Have a mydriatic pupil diameter of less than 6mm.
  • Have participated in clinical trial within 7 days prior to study enrollment.
  • Be an employee (e.g., Investigator, Coordinator, or Technician) or immediate family member (including partner, child, parent, grandparent, grandchild, or sibling) of an employee of the clinical site or study sponsor.
  • Be currently pregnant or lactating.

Treatment and study plan

IOL Decentration Assessment

Diagnostic Test

This study assesses two methods to measure IOL decentration. Each subject will be evaluated in only one eye with both methods for assessing IOL decentration:

(i) retro-illuminated slit lamp image analysis (objective slit lamp method) and (ii) subjective slit lamp grading method. There is no treatment or intervention on this study.

Other names: Basic Science

Primary outcomes

  1. IOL Decentration

    Time frame: 3 months

    • Magnitude of Decentration relative to the center of the pupil.
    • Direction of Decentration relative to the center of the pupil

Sponsors and collaborators

Lead sponsor

Johnson & Johnson Surgical Vision, Inc.

Industry

Registry information

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Oct 20, 2025
Registry last updated
Mar 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.